High-mobility group box-1 protein in tracheal aspirates from premature infants: Relationship with bronchopulmonary dysplasia and steroid therapy

Journal of Perinatology

Volumn 30, Issue 9, 2010, Pages 610-615

  Aghai, Z H ^a,b   Saslow, J G ^a,b   Meniru, C ^a   Porter, C ^a   Eydelman, R ^a   Bhat, V ^a,b   Stahl, G ^a,b   Sannoh, S ^a,b   Pyon, K ^a   Hewitt, C ^a,b   Bhandari, V ^c  

^a Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HIGH MOBILITY GROUP B1 PROTEIN; LUNG SURFACTANT; OXYGEN;

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CONTROLLED STUDY; DEATH; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; PREMATURITY; STEROID THERAPY; TRACHEAL ASPIRATION PROCEDURE;

BRONCHOPULMONARY DYSPLASIA; DEXAMETHASONE; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; RESPIRATION, ARTIFICIAL; SPUTUM; STEROIDS; TRACHEA;

EID: 77956267570     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2010.16     Document Type: Article

References (35)

1. Bhandari A, Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics 2009; 123: 1562-1573.
2. Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2005. Natl Vital Stat Rep 2006; 55: 1-18.
3. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR et al. Trends in neonatal morbidity and mortality for very low birth weight infants. Am J Obstet Gynecol 2007; 196: 147 e141-148.
4. Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ. HMGB1 as a DNA-binding cytokine. J Leukoc Biol 2002; 72: 1084-1091.
5. Wang H, Yang H, Tracey KJ. Extracellular role of HMGB1 in inflammation and sepsis. J Intern Med 2004; 255: 320-331.
6. Ogawa EN, Ishizaka A, Tasaka S, Koh H, Ueno H, Amaya F et al. Contribution of highmobility group box-1 to the development of ventilator-induced lung injury. Am J Respir Crit Care Med 2006; 174: 400-407.
7. Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003; 14: 523-535.
8. Bourbia A, Cruz MA, Rozycki HJ. NF-kappaB in tracheal lavage fluid from intubated premature infants: association with inflammation, oxygen, and outcome. Arch Dis Child Fetal Neonatal Ed 2006; 91: F36-F39.
9. Aghai ZH, Kode A, Saslow JG, Nakhla T, Farhath S, Stahl GE et al. Azithromycin suppresses activation of nuclear factor-kappa B and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants. Pediatr Res 2007; 62: 483-488.
10. Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 2006; 12: 1286-1293.
11. Lutz W, Stetkiewicz J. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation. Int J Occup Med Environ Health 2004; 17: 245-254.
12. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248-251.
13. Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, Tanaka M et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 2004; 170: 1310-1316.
14. Ding BS, Hong N, Christofidou-Solomidou M, Gottstein C, Albelda SM, Cines DB et al. Anchoring fusion thrombomodulin to the endothelial lumen protects injury-induced lung thrombosis and inflammation. Am J Respir Crit Care Med 2009; 180(3): 247-256.
15. van Zoelen MA, Ishizaka A, Wolthuls EK, Choi G, van der Poll T, Schultz MJ. Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia. Shock 2008; 29: 441-445.
16. Crouser E, Exline M, Knoell D, Wewers MD. Sepsis: links between pathogen sensing and organ damage. Curr Pharm Des 2008; 14: 1840-1852.
17. Lionetti V, Recchia FA, Ranieri VM. Overview of ventilator-induced lung injury mechanisms. Curr Opin Crit Care 2005; 11: 82-86.
18. Bhandari V, Elias JA. The role of angiopoietin 2 in hyperoxia-induced acute lung injury. Cell Cycle 2007; 6: 1049-1052.
19. Buhimschi CS, Baumbusch MA, Dulay AT, Oliver EA, Lee S, Zhao G et al. Characterization of RAGE, HMGB1, and S100{beta} in inflammation-induced preterm birth and fetal tissue injury. Am J Pathol 2009; 175(3): 958-975.
20. Bry K, Whitsett JA, Lappalainen U. IL-1beta disrupts postnatal lung morphogenesis in the mouse. Am J Respir Cell Mol Biol 2007; 36: 32-42.
21. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999; 160: 1333-1346.
22. Thomson A, Bhandari V. Pulmonary biomarkers of bronchopulmonary dysplasia. Biomarker Insights 2008; 3: 361-373.
23. Zamora R, Grishin A, Wong C, Boyle P, Wang J, Hackam D et al. High-mobility group box 1 protein is an inflammatory mediator in necrotizing enterocolitis: protective effect of the macrophage deactivator semapimod. Am J Physiol Gastrointest Liver Physiol 2005; 289: G643-G652.
24. Okazaki K, Kondo M, Kato M, Kakinuma R, Nishida A, Noda M et al. Elevation of highmobility group box 1 concentration in asphyxiated neonates. Neonatology 2008; 94: 105-109.
25. Lang CH, Silvis C, Deshpande N, Nystrom G, Frost RA. Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle. Shock 2003; 19: 538-546.
26. Treutiger CJ, Mullins GE, Johansson AS, Rouhiainen A, Rauvala HM, Erlandsson-Harris H et al. High mobility group 1 B-box mediates activation of human endothelium. J Intern Med 2003; 254: 375-385.
27. Mullins GE, Sunden-Cullberg J, Johansson AS, Rouhiainen A, Erlandsson-Harris H, Yang H et al. Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scand J Immunol 2004; 60: 566-573.
28. Aghai ZH, Kumar S, Farhath S, Kumar MA, Saslow J, Nakhla T et al. Dexamethasone suppresses expression of nuclear factor-kappa B in the cells of tracheobronchial lavage fluid in premature neonates with respiratory distress. Pediatr Res 2006; 59: 811-815.
29. Li W, Li J, Ashok M, Wu R, Chen D, Yang L et al. A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1. J Immunol 2007; 178: 3856-3864.
30. Groneck P, Reuss D, Gotze-Speer B, Speer CP. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. J Pediatr 1993; 122: 938-944.
31. Murch SH, MacDonald TT, Wood CB, Costeloe KL. Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Thorax 1992; 47: 44-47.
32. DAngio CT, Basavegowda K, Avissar NE, Finkelstein JN, Sinkin RA. Comparison of tracheal aspirate and bronchoalveolar lavage specimens from premature infants. Biol Neonate 2002; 82: 145-149.
33. Bhandari V, Choo-Wing R, Lee CG, Yusuf K, Nedrelow JH, Ambalavanan N et al. Developmental regulation of NO-mediated VEGF-induced effects in the lung. Am J Respir Cell Mol Biol 2008; 39: 420-430.
34. Lassus P, Heikkila P, Andersson LC, von Boguslawski K, Andersson S. Lower concentration of pulmonary hepatocyte growth factor is associated with more severe lung disease in preterm infants. J Pediatr 2003; 143: 199-202.
35. Gong Q, Xu JF, Yin H, Liu SF, Duan LH, Bian ZL. Protective effect of antagonist of high-mobility group box 1 on lipopolysaccharide-induced acute lung injury in mice. Scand J Immunol 2009; 69: 29-35.